Ajuste direto para aquisição de T1140 - TRIPTORRELINA (PÓ P/ SOL INJ) [0.1 MG/ML; 1 ML; FRS] e T202 - TRIPTORRELINA (PÓ P/ SUSP INJ) [3,75MG; FRS/ SERINGA] para suprir necessidades na área da saúde.

ID 12423632 · Portal BASE
Price
Base Price
€18,450 .00
Effective Price
€6,153 .00 -66.7%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
JANSSEN - CILAG FARMACÊUTICA LDA
NIF 500189412
Company
Dates
Publication
06 Jan 2026
Celebration
05 Jan 2026
Contracting Entity
Centro Hospitalar de Lisboa Ocidental, EPE
NIF 507618319
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
18450.0
Total effective price
6153.0
Ratio
0.3335
Direction
reduction
Rule
A9 price reduction: ratio 0.3335 outside [0.5, 1.5]
Detected 2026-03-06